Oxford Finance announced the closing of a $3 million senior secured term loan with MDRejuvena, Inc. Proceeds from the loan are being used for the commercialization and continued development of the company’s Rejuvaphyl and daily skincare products.

Rejuvaphyl is the MDRejuvena brand of high potency skincare products that contain the proprietary and patented ingredient Phytochromatic MD Complex. Phytochromatic MD Complex is a naturally-derived, plant-based ingredient clinically proven to provide a number of important skincare benefits.

“MDRejuvena is led by a team of highly accomplished executives who have a successful track record in the skincare industry,” said Christopher A. Herr, senior managing director at Oxford Finance. “Oxford is pleased to provide funds to support the execution of the company’s global marketing plan for its innovative product line.”

David F. Hale, executive chairman and chief executive officer of MDRejuvena stated, “We are excited about the opportunity to work with Oxford.  This financing will allow us to continue to build our business, expand our sales force into new markets, and develop our pipeline of new products.  Oxford’s support of MDRejuvena is an important step on the path to our success and will accelerate awareness of the MDRejuvena brand.”

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide.